The editors of the global industry magazine \u201cThe Lawyer\u201d have nominated GSK Stockmann Luxembourg for the prestigious \u201cEuropean Awards 2018\u201d in the category \u201cLaw firm of the Year: Benelux\u201d. <\/p>\n
\u201cWe are very pleased about the nomination and the associated international recognition\u201d, says Dr. Oliver Gl\u00fcck, Managing Partner at GSK Stockmann and adds: \u201cIt reflects the high quality of the legal services provided by our Luxembourg colleagues. I congratulate on this success. \u201dThis nomination is a further proof that GSK Stockmann is able to push forward its internationalization.\u201d<\/p>\n
Andreas Heinzmann, partner in the Luxembourg office of GSK Stockmann says: \u201cI am very proud of our team. We are pleased that the dynamic development of GSK Luxembourg has received such an excellent response in the market.\u201d<\/p>\n
Shortly after its establishment in spring 2016, the strongly international-oriented Luxembourg office of GSK has gone on the road to success. The rapidly growing Luxembourg team advises international clients on cross-border transactions and projects in the fields of investment funds, private equity, corporate law, real estate, capital markets, banking & finance, regulatory law and tax law. In addition to Europe, the steadily growing business from Asia has also contributed to this growth.<\/p>\n
As the leading financial centre in the EU, Luxembourg is an important platform for the development and use of a large number of financial products by international investors. Other industries are also developing positively, which should give the location even more stability.<\/p>\n
The press release is available to download.<\/p>\n","protected":false},"excerpt":{"rendered":"
The editors of the global industry magazine \u201cThe Lawyer\u201d have nominated GSK Stockmann Luxembourg for the prestigious \u201cEuropean Awards 2018\u201d in the category \u201cLaw firm of the Year: Benelux\u201d. \u201cWe are very pleased about the nomination and the associated international recognition\u201d, says Dr. Oliver Gl\u00fcck, Managing Partner at GSK Stockmann and adds: \u201cIt reflects the … Continued<\/a><\/p>\n","protected":false},"author":35,"featured_media":31669,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[639],"tags":[],"ausgabe":[],"class_list":["post-31886","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firm"],"acf":{"postdownloads_lux":null,"pressekontakt":{"name":"","email":"","phone":""},"ansprechpartner":[{"anwalt":30553}]},"_links":{"self":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/comments?post=31886"}],"version-history":[{"count":0,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31886\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media\/31669"}],"wp:attachment":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media?parent=31886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/categories?post=31886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/tags?post=31886"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/ausgabe?post=31886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}